VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
37 hedge funds and large institutions have $1.9M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
73% less capital invested
Capital invested by funds: $7.06M → $1.9M (-$5.15M)
Holders
37
Holding in Top 10
–
Calls
$672K
Puts
$2K
Top Buyers
| 1 | +$464K | |
| 2 | +$47.7K | |
| 3 | +$18K | |
| 4 |
AGM
Alpine Global Management
New York
|
+$16.7K |
| 5 |
HF
HRT Financial
New York
|
+$15K |
Top Sellers
| 1 | -$131K | |
| 2 | -$86.8K | |
| 3 | -$41.9K | |
| 4 |
Jane Street
New York
|
-$40.1K |
| 5 |
Morgan Stanley
New York
|
-$28.6K |